Evidence map›Paper›PMID 41393536›Full record

ArticleCureus2025

A Novel Case of Robotic Retroperitoneal Lymph Node Dissection for Metastatic Sertoli Cell Tumour: A Case Report.

Pranav Patel, Stuart Henderson, Kamran Haq, Ben Challacombe

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pranav PatelSurgery, Southampton General Hospital NHS Foundation Trust, Southampton, GBR.
Stuart HendersonUrology, Guy's and St Thomas' NHS Foundation Trust, London, GBR.
Kamran HaqUrology, Guy's and St Thomas' NHS Foundation Trust, London, GBR.
Ben ChallacombeUrology, Guy's and St Thomas' NHS Foundation Trust, London, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sertoli cell tumours of the testes (SCTT) are a rare subgroup of sex cord stromal tumours. This report describes a novel use of robotic retroperitoneal lymph node dissection (RPLND) in a rare case of metastatic disease that posed significant diagnostic challenges. A 60-year-old male presented with a left testicular mass; post-orchidectomy histological review confirmed high-risk Sertoli cell tumour. A subsequent PET-CT identified metastatic para-aortic lymph nodes; an incidental finding of a non-functioning paraganglioma was also noted. The patient underwent a successful robotic RPLND, performed using the DaVinci Xi robotic platform. Postoperative recovery was uneventful, and the patient was discharged on postoperative day two. Histology confirmed metastasis in two out of 10 lymph nodes. This report highlights the potential of robotic RPLND as a viable treatment course, with its success emphasising the critical role of multidisciplinary team collaboration. While we describe a novel approach, further studies and long-term oncological outcomes in larger patient cohorts are necessary to establish definitive treatment guidelines.

Indexed as

neuro-endocrine tumouronco-surgeryretroperitoneal lymph node dissectionrobotic surgerysertoli cell tumor

Identifiers

PMID41393536
PMCPMC12700305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.